胰岛素卡尺用于血糖控制对急诊与重症患者血糖控制的效果
该研究为前瞻性单盲随机平行对照干预研究,纳入2015年11月至2017年11月嘉兴市第一医院急诊科与ICU的100例需胰岛素输注治疗的严重高血糖患者,随机分为卡尺组(使用专利产品胰岛素卡尺调节胰岛素剂量)与常规组(使用纸质胰岛素剂量修改方案),每组50例。最终92例纳入分析(卡尺组47例、常规组45例)。卡尺组在6-72小时各时间点血糖测量值显著低于常规组,血糖不稳定指数(GLUGLI)与平均血糖波动幅度(GLUMAGE)显著降低,血糖达标比例显著提高(41.99% vs 27.18%,P<0.01),低血糖发生率有下降趋势(8.51% vs 15.56%)但无统计学差异。两组血糖变异系数、胰岛素剂量、ICU住院时间、住院费用等无显著差异。
要点
- 卡尺组血糖达标比例41.99%(579/1379)显著高于常规组27.18%(362/1332),P<0.01。
- 卡尺组GLUGLI为12.96(8.73,19.58),常规组为23.27(13.07,44.61),卡尺组显著降低,P<0.01。
- 卡尺组GLUMAGE为0.66±0.22 mmol/L,常规组为0.87±0.28 mmol/L,卡尺组显著降低,P<0.01。
- 低血糖发生率卡尺组8.51%(4/47)vs 常规组15.56%(7/45),有下降趋势但无统计学差异(P>0.05)。
- 6-72小时各时间点血糖测量值卡尺组显著低于常规组;两组血糖变异系数、胰岛素剂量、ICU住院时间及费用无显著差异。
适用人群与场景
- 急诊科与ICU收治的需胰岛素输注治疗的严重高血糖患者,年龄、性别不限,纳入2015年11月至2017年11月嘉兴市第一医院。
- 排除标准原文未明确列出;最终分析排除数据不完整及中途退出者,92例纳入分析(卡尺组47例、常规组45例)。
诊断标准与关键阈值
- 血糖控制目标原文未给出具体数值;以「血糖达标比例」为指标,达标标准原文未写明。
- 血糖监测频率:胰岛素使用后每2小时一次,16-72小时后每4小时一次。
处置流程与药物剂量
- 卡尺组:使用专利产品胰岛素卡尺调节胰岛素剂量以控制血糖。
- 常规组:使用纸质胰岛素剂量修改方案调节胰岛素剂量以控制血糖。
研究设计与关键结果
- 研究类型:前瞻性单盲随机平行对照干预研究;样本量100例随机,最终92例分析(卡尺组47例、常规组45例);单中心(嘉兴市第一医院)。
- 人群:急诊科与ICU需胰岛素输注治疗的严重高血糖患者;两组基线性别、年龄、APACHE II、SOFA、感染、糖尿病史、糖化血红蛋白、入院血糖、术后比例、主要疾病及影响血糖主要因素无显著差异。
- 干预与对照:卡尺组用胰岛素卡尺调节胰岛素剂量,常规组用纸质胰岛素剂量修改方案。
- 主要终点结果:卡尺组血糖达标比例41.99%(579/1379)vs 常规组27.18%(362/1332),P<0.01。
- 关键次要终点:GLUGLI卡尺组12.96(8.73,19.58)vs 常规组23.27(13.07,44.61),P<0.01;GLUMAGE卡尺组0.66±0.22 mmol/L vs 常规组0.87±0.28 mmol/L,P<0.01;6-72小时各时间点血糖卡尺组显著低于常规组。
- 低血糖发生率卡尺组8.51%(4/47)vs 常规组15.56%(7/45),P>0.05;血糖变异系数、胰岛素剂量、低血糖测量占比、ICU住院时间、住院时间、院内感染发生率、预后及费用两组无显著差异。
证据类型、等级与局限
- 证据类型:前瞻性单盲随机平行对照干预研究;中国临床试验注册中心注册号ChiCTR1800015024。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对急诊与重症患者,胰岛素卡尺用于血糖控制对达成血糖控制目标、减少血糖波动和降低低血糖发生率具有良好应用价值。
- 本研究显示卡尺组血糖达标比例更高、GLUGLI与GLUMAGE更低;低血糖发生率有下降趋势但无统计学差异;两组胰岛素剂量、ICU住院时间及费用无显著差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To observe the effects of insulin caliper for blood glucose control on glycemic central tendency, fluctuation and incidence of hypoglycemia, etc., in emergent and critical patients to evaluate its application value.
METHODS: A prospective single-blinded randomized parallel controlled intervention study was conducted. One hundred patients with severe hyperglycemia requiring treatment with insulin infusion admitted to emergency department and intensive care unit (ICU) of the First Hospital of Jiaxing from November 2015 to November 2017 were enrolled, and they were divided into the caliper group (used patented product insulin calipers for blood glucose control to adjust insulin dose for blood glucose control) and the conventional group (used paper-based insulin dose modification scheme to adjust insulin dose for blood glucose control) on average by random number table, 50 in each group. The gender, age, acute physiology and chronic health evaluation II (APACHE II), sequential organ failure assessment (SOFA), the principal diseases, main factors affecting blood glucose (hepatic and renal insufficiency, hypoglycemic drugs, glucocorticoids, mechanical ventilation, enteral nutrition, parenteral nutrition, intravenous glucose use, etc.), blood glucose levels at each time node (once every 2 hours after insulin use and once every 4 hours after 16-72 hours), glycemic coefficient of variance (CV), glycemic lability index (GLUGLI) and mean amplitude of glycemic excursion (GLUMAGE), insulin dose, incidence of hypoglycemia, proportion of achieving the glucose control target at each time point, the length of ICU stay and hospitalization cost per patient were recorded and compared between the two groups.
RESULTS: After excluding those with incomplete data and withdraw in the midway, 92 patients were enrolled in the analysis finally, 47 in caliper group and 45 in conventional group. There were no significant differences in the incidence of the gender, age, APACHE II, SOFA, presence of infection at admission, previous diabetes history, glycosylated hemoglobin level, blood glucose at admission, proportion of patients after surgery, major diseases at admission and major factors affecting blood glucose between the two groups. A total of 1 379 blood glucose measurements were obtained in the caliper group and 1 332 blood glucose measurements were obtained in the conventional group. The glycemic measurements in caliper group were significantly lower than that in conventional group at each time point from 6-72 hours. Compared with conventional group, GLUGLI and GLUMAGE were significantly decreased in the caliper group [GLUGLI: 12.96 (8.73, 19.58) vs. 23.27 (13.07, 44.61), GLUMAGE (mmol/L): 0.66±0.22 vs. 0.87±0.28, both P < 0.01]; there was a tendency towards decreasing incidence of hypoglycemia in the caliper group [8.51% (4/47) vs. 15.56% (7/45)], but no statistical difference was found (P > 0.05); the proportion of achieving the glucose control target was significantly increased in the caliper group [41.99% (579/1 379) vs. 27.18% (362/1 332), P < 0.01]. There were no significant differences in glycemic CV, insulin dose, proportion of hypoglycemic measurements in total measurements, and the length of ICU stay, the length of hospital stay, incidence of nosocomial infection, patient prognosis and cost between the two groups.
CONCLUSIONS: For emergent and critical patients, insulin caliper for blood glucose control presents favorable application value for achieving glucose control target, reducing glycemic fluctuation, and lowering the incidence of hypoglycemia.
CLINICAL TRIAL REGISTRATION: China clinical trial registration center, ChiCTR1800015024.
参考来源
- Yu H, Zhang L, Xu S, et al. [Effects of insulin caliper for blood glucose control on glucose control in emergent and critical patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 30220280. doi:10.3760/cma.j.issn.2095-4352.2018.08.012
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。